Access the full text.
Sign up today, get DeepDyve free for 14 days.
Guoguang Lu (2000)
TOP: a new method for protein structure comparisons and similarity searchesJournal of Applied Crystallography, 33
Axel Brüngera, Paul Adamsb, G. Clorec, Warren DeLanod, Piet Grose, Ralf Grosse-Kunstlevea, Jian-Sheng Jiangf, John Kuszewskic, Michael Nilgesg, Navraj Pannuh, Randy Readi, Luke Riceb, Thomas Simonsonj, Gregory Warrenb (1998)
Crystallography & NMR system: A new software suite for macromolecular structure determination.Acta crystallographica. Section D, Biological crystallography, 54 Pt 5
(1992)
Molecular replacement with X-PLOR: PC-refinement and free R value
I. Shindyalov, P. Bourne (1998)
Protein structure alignment by incremental combinatorial extension (CE) of the optimal path.Protein engineering, 11 9
Reto Koradi, M. Billeter, K. Wüthrich (1996)
MOLMOL: a program for display and analysis of macromolecular structures.Journal of molecular graphics, 14 1
Z. Otwinowski, W. Minor (1997)
Processing of X-ray diffraction data collected in oscillation mode.Methods in enzymology, 276
M.J Banfield, D. King, A. Mountain, R. Brady (1997)
VL:VH domain rotations in engineered antibodies: Crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructsProteins: Structure, 29
Collaborative Computational (1994)
The CCP4 suite: programs for protein crystallography.Acta crystallographica. Section D, Biological crystallography, 50 Pt 5
(1992)
Collaborative Computational Project , N . The CCP 4 Suite : Programs for Protein Crystallography
P. Kwong, R. Wyatt, James Robinson, R. Sweet, J. Sodroski, W. Hendrickson (1998)
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibodyNature, 393
N. Guex, M. Peitsch (1997)
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingELECTROPHORESIS, 18
J. Major, R. Liou, L. Sun, L. Yu, S. Starnes, M. Fung, T. Chang, N. Chang (1994)
Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.Human antibodies and hybridomas, 5 1-2
<h1>Introduction.</h1> The structures of antibodies raised against peptides representing HIV‐1 epitopes are of intrinsic interest in the battle against AIDS. Antibodies that neutralize the virus, effectively stopping its reproduction, are of particular interest because the structure of a neutralizing antibody should contain information concerning the way neutralization can be accomplished. To that end, structures have been published describing neutralizing antibodies raised against representatives of the third hypervariable region (V3) of the HIV‐1 envelope glycoprotein subunit, gp120 (Fabs 59.1, 58.2, and 50.1, PDB accession numbers 1ACY, 1F58, and 1GGC). The subregion from which the peptides derive, amino acid residues 308–332, is known as the principal neutralization determinant (PND). Unfortunately, it is encoded by one of the most mutation prone sequences of the HIV genome, and the neutralizing capability of an antibody against the PND does not often generalize to mutated strains. The hope has been that structures would provide a basis for understanding how to completely neutralize the virus using antibodies, but this hope has not yet been realized. The neutralizing antibody investigated here, G3‐519, recognizes an epitope from the fourth conserved region (C4) of gp120 that plays an important role in interaction with CD4 (see details below). It
Proteins: Structure Function and Bioinformatics – Wiley
Published: Jan 15, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.